Prokarium secures $10 million for thermostable vaccine development
Prokarium and Probiomed in UK-Mexico collaboration to manufacture thermostable vaccines
Prokarium to develop first vaccine to protect against both modes of Zika transmission
Prokarium receives funding to further develop new vaccine for Chlamydia
Prokarium receives £225,000 grant to develop next-generation vaccines
